UK’s MHRA approves Beyfortus (nirsevimab) to prevent RSV in infants

Image: Each year, around 30,000 children under the age of five are hospitalised in the UK because of RSV. Credit: -Rita-👩‍🍳 und 📷 my ❤ from Pixabay.